TMDX Q2 2023 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$52M+155.7% YoY

Gross Profit

$37M70.0% margin

Operating Income

-$906,000-1.7% margin

Net Income

-$1M-1.9% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

+26.3%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$7M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$690M

Total Liabilities

$545M

Stockholders' Equity

$145M

Cash & Equivalents

$582M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52M	$21M	+155.7%
Gross Profit	$37M	$14M	+156.0%
Operating Income	-$906,000	-$10M	+90.7%
Net Income	-$1M	-$12M	+91.3%

Revenue Segments

Product

$42M81%

Service

$10M19%

Geographic Segments

UNITED STATES

$3M87%

Other Countries

$403,00013%